Arcinova have established expertise and technologies that are routinely applied to the understanding of active pharmaceutical ingredients (APIs), how best to formulate them for clinical and non-clinical applications, what their stability characteristics are and how to manufacture the formulations of choice reproducibly.
Formulation development programs can be conducted in isolation but are most powerful when combined with some or all of the synthetic, analytical, microbiological, clinical product manufacturing and regulatory CMC expertise available within Arcinova.
Our range of services related to drug product include:
• Materials science and spectroscopic investigations
• Non-clinical formulation development (oral and IV)
• Clinical formulation development (oral and IV)
• Stability testing
• Clinical Product Manufacture (oral and IV)
• Clinical product manufacture (Cytotoxic/high potency/radiolabelled products)
• QC testing and QP release
CPhI WorldwideCPhI Worldwide will be attended by Nathalie Huther, Business Development Manager Europe. Nathalie will be located at the DIT stand: 9J40
CPhI WorldwideDates: 9th - 11th OctoberLocation: Madrid, Spain
CMAC Open DayThe CMAC Open Day event will be attended by Gareth Jenkins, Chief Scientific Officer.
CMAC Open DayDates: 25th - 26th OctoberLocation: Glasgow, UK
Organic Process Research & DevelopmentThe Organic Process R&D conference will be attended by Nathalie Huther, Business Development Manager Europe.
Organic Process Research & DevelopmentDates: 29th - 31st OctoberLocation: Milan, Italy